University Of Otago

University Of Otago Research & Enterprise Division, based in Dunedin, New Zealand, operates as a tax-exempt academic research institution that acts as a federal grant recipient and subrecipient on biomedical, environmental, and policy research programs funded by U.S. federal agencies. The division competes as a prime recipient on open federal grant opportunities and serves as a subrecipient on multi-site research awards managed by U.S. universities as prime recipients, with no federal contract prime or IDV presence in its footprint.

The division's customer base spans eighteen distinct federal agencies, concentrated among health and defense funders. The top five customers by award count account for 64% of recent grants: the National Institute on Aging (9 awards), the National Institutes of Health (6 awards), the Department of the Navy (5 awards), the Bureau of East Asian and Pacific Affairs (4 awards), and the Office of Naval Research (3 awards). Potential-value concentration differs from volume concentration—the Centers for Disease Control and Prevention Morgantown site carries the highest single-award potential value at $24 thousand, followed by the National Oceanic and Atmospheric Administration at $10 thousand—indicating a portfolio of modest-scale individual grants rather than large single awards. The division has received forty-two awards total across prime and sub roles; combined potential value is $35 thousand, but combined obligated dollars across all awards total $7.5 million, reflecting actual performance invoicing significantly exceeding stated project ceilings.

Representative prime recipient work includes a cooperative agreement with the Animal and Plant Health Inspection Service (awarded May 1, 2026, completing September 30, 2026) for CRISPR-based eDNA detection methods development for invasive rat biosurveillance in remote ecosystems, a project grant from the Office of Naval Research (January 26, 2024) supporting the KozWaves 2024 Australasian Conference on Wave Science, and project grants from the Bureau of East Asian and Pacific Affairs (January 2023 through October 2024) funding public lectures and delegation hosting centered on U.S.-China relations and social enterprise education. In its subrecipient role, the division serves as a research site on multi-institutional awards, including the DIAN-TU-001 and DIAN-TU-002 trials (Washington University in St. Louis as prime, National Institutes of Health funding) for dominantly inherited Alzheimer's disease research, a photon-counting CT image reconstruction project under University of Massachusetts Lowell (National Institutes of Health), a translational genomics study in gout under the University of Alabama at Birmingham, and a long-term cohort neuroimaging study directed by Duke University that leverages the Dunedin Multidisciplinary Health and Development Research Unit to recruit, collect multimodal neuroimaging, health, and biomarker data from 150–230 participants annually through 2027. Activity has remained modest and episodic—one award in 2022, six in 2023, six in 2024, two in 2025, and one in 2026—with no visible trajectory toward sustained volume growth.